I've led corporate strategy and operations across HIMSS, HALO Precision Diagnostics, Ginkgo Bioworks, Deloitte Consulting, and the National Institutes of Health.
At HALO, I led the four-month go-to-market launch of three genetic testing products in California and Florida, projected to generate approximately $10M annually. At HIMSS, I directed a new Advisory Services go-to-market strategy 90 days ahead of schedule, with $1–3M in projected revenue.
I turn market analysis, operational data, and cross-functional input into roadmaps, OKRs, KPI dashboards, and clear executive and Board recommendations. I'm PMP-certified and comfortable owning high-priority initiatives in complex, ambiguous environments.
